ARtificial Intelligence for Gross Tumour vOlume Segmentation

Active, not recruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

December 1, 2024

Conditions
Lung Cancer
Interventions
RADIATION

Radiotherapy

Radiotherapy

Trial Locations (1)

6229ET

Maastro Clinic, Maastricht

All Listed Sponsors
collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

The Netherlands Cancer Institute

OTHER

collaborator

University Hospital, Basel, Switzerland

OTHER

collaborator

University of Zurich

OTHER

collaborator

University Medical Center Groningen

OTHER

collaborator

Isala

OTHER

collaborator

Tianjin Medical University Cancer Institute and Hospital

OTHER

collaborator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

collaborator

Cardiff University

OTHER

collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

collaborator

The Christie NHS Foundation Trust

OTHER

collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

collaborator

Hospital Israelita Albert Einstein

OTHER

collaborator

University of Pennsylvania

OTHER

collaborator

Liverpool Hospital, South Western Sydney Local Health District

UNKNOWN

collaborator

MVR Cancer Centre and Research Institute India

UNKNOWN

collaborator

H. Lee Moffitt Cancer Center and Research Institute

OTHER

collaborator

Oslo University Hospital

OTHER

collaborator

Christian Medical College, Vellore, India

OTHER

collaborator

Fudan University

OTHER

collaborator

Swiss Institute of Bioinformatics

UNKNOWN

collaborator

Guangdong Provincial People's Hospital

OTHER

collaborator

National Institute of Technology Calicut

UNKNOWN

collaborator

Maastricht University

OTHER

lead

Maastricht Radiation Oncology

OTHER